Effects of dietary eicosapentaenoic acid (EPA) supplementation in high-fat fed mice on lipid metabolism and apelin/APJ system in skeletal muscle

• Published in: PloS one 2013-11, Vol.8 (11), p.e78874
• Main Authors: Bertrand, Chantal, Pignalosa, Angelica, Wanecq, Estelle, Rancoule, Chloé, Batut, Aurélie, Deleruyelle, Simon, Lionetti, Lillà, Valet, Philippe, Castan-Laurell, Isabelle
• Format: Article
• Language: English
• Subjects: Acids; Adipocytes; Adipokines; Adipose tissue; Analysis; Animals; Apelin; Autocrine signalling; Biosynthesis; Blood glucose; Blood Glucose - metabolism; Body fat; Body weight gain; Cancer; Carbohydrates; Cell Line; Diabetes; Diet; Dietary Fats - adverse effects; Dietary Fats - pharmacology; Dietary Supplements; Eicosapentaenoic acid; Eicosapentaenoic Acid - pharmacology; Fatty acids; Fatty liver; Gene Expression Regulation - drug effects; Gesta; High fat diet; Hypoxia; Insulin; Insulin resistance; Intercellular Signaling Peptides and Proteins - biosynthesis; Lipid metabolism; Lipids; Male; Metabolism; Mice; Muscle Proteins - biosynthesis; Muscle, Skeletal - metabolism; Muscle, Skeletal - pathology; Muscles; Musculoskeletal system; Myocytes; Obesity; Obesity - metabolism; Obesity - pathology; Obesity - prevention & control; Omega 3 fatty acids; Oxidation; Paracrine signalling; Physiological aspects; Proteins; Rodents; Secretion; Sensitizing; Skeletal muscle; Steatosis; Triglycerides; Type 2 diabetes; Unsaturated fatty acids
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0078874

Various studies have shown that eicosapentaenoic acid (EPA) has beneficial effects on obesity and associated disorders. Apelin, the ligand of APJ receptor also exerts insulin-sensitizing effects especially by improving muscle metabolism. EPA has been shown to increase apelin production in adipose tissue but its effects in muscle have not been addressed. Thus, the effects of EPA supplementation (36 g/kg EPA) in high-fat diet (HFD) (45% fat, 20% protein, 35% carbohydrate) were studied in mice with focus on muscle lipid metabolism and apelin/APJ expression. Compared with HFD mice, HFD+EPA mice had significantly less weight gain, fat mass, lower blood glucose, insulinemia and hepatic steatosis after 10 weeks of diet. In addition, EPA prevented muscle metabolism alterations since intramuscular triglycerides were decreased and β-oxidation increased. In soleus muscles of HFD+EPA mice, apelin and APJ expression were significantly increased compared to HFD mice. However, plasma apelin concentrations in HFD and HFD+EPA mice were similar. EPA-induced apelin expression was confirmed in differentiated C2C12 myocytes but in this model, apelin secretion was also increased in response to EPA treatment. In conclusion, EPA supplementation in HFD prevents obesity and metabolic alterations in mice, especially in skeletal muscle. Since EPA increases apelin/APJ expression in muscle, apelin may act in a paracrine/autocrine manner to contribute to these benefical effects.